KRISHI
ICAR RESEARCH DATA REPOSITORY FOR KNOWLEDGE MANAGEMENT
(An Institutional Publication and Data Inventory Repository)
"Not Available": Please do not remove the default option "Not Available" for the fields where metadata information is not available
"1001-01-01": Date not available or not applicable for filling metadata infromation
"1001-01-01": Date not available or not applicable for filling metadata infromation
Please use this identifier to cite or link to this item:
http://krishi.icar.gov.in/jspui/handle/123456789/77736
Title: | Pathomorphological alterations in cisplatin induced testicular toxicity and its amelioration by gallic acid |
Other Titles: | Not Available |
Authors: | Roopadevi YS Rao S Nadoor P Byregowda SM Narayanaswamy HD Krishnamoorthy P Girish MH |
ICAR Data Use Licennce: | http://krishi.icar.gov.in/PDF/ICAR_Data_Use_Licence.pdf |
Author's Affiliated institute: | Veterinary College, Hebbal, Bengaluru Veterinary College, Shivamogga ICAR::National Institute of Veterinary Epidemiology and Disease Informatics |
Published/ Complete Date: | 2023-05-15 |
Project Code: | Not Available |
Keywords: | Gallic acid cisplatin Testicular toxicity Sequential pathomorphology |
Publisher: | The Pharma Innovation Journal |
Citation: | 1. Roopadevi YS, Rao S, Nadoor P, Byregowda SM, Narayanaswamy HD, Krishnamoorthy P, Girish MH. 2023. Pathomorphological alterations in cisplatin induced testicular toxicity and its amelioration by gallic acid. The Pharma Innovation Journal, 12(5): 2129-2136. |
Series/Report no.: | Not Available; |
Abstract/Description: | The study was aimed to investigate the efficacy of a phytochemical gallic acid (GA) in preventing the pathomorphological alterations induced by cisplatin (CP) in testicular tissue of Wistar albino rats. One hundred and eight Wistar albino rats were equally divided into six groups. Group I served as normal control, Group II received single dose of intraperitoneal injection of CP at 7.5 mg/kg bw, Group III received GA at 75 mg/kg bw for 45 days, Group IV was treated with GA daily for 15 days prior to CP injection and discontinued post CP injection, Group V received CP injection and concurrently received GA for 45 days post CP injection and Group VI was treated with GA for 15 days prior to CP injection and continued for 45 days post CP injection. The testis samples collected on 7th, 14th, 28th and 45th day of post CP injection were subjected for histopathological examination to study the sequential pathomorphological changes. CP administration produced moderate congestion and interstitial oedema, severe seminiferous tubular atrophy, tubular cell degeneration and necrosis. The Gallic acid supplemented groups showed significant improvement in CP induced pathological changes. The pre + concurrent GA supplementation (Group VI) produced much earlier improvement in CP induced pathological changes than only pre and only concurrent GA supplementation. It was concluded that, GA supplementation have protective role against CP induced testicular toxicity. |
Description: | Not Available |
ISSN: | 2277-7695 |
Type(s) of content: | Research Paper |
Sponsors: | Not Available |
Language: | English |
Name of Journal: | The Pharma Innovation Journal |
Journal Type: | Included NAAS Journal list |
NAAS Rating: | 5.23 |
Volume No.: | 12(5) |
Page Number: | 2129-2136 |
Name of the Division/Regional Station: | Not Available |
Source, DOI or any other URL: | https://www.thepharmajournal.com/archives/2023/vol12issue5/PartZ/12-5-368-103.pdf |
URI: | http://krishi.icar.gov.in/jspui/handle/123456789/77736 |
Appears in Collections: | AS-NIVEDI-Publication |
Files in This Item:
There are no files associated with this item.
Items in KRISHI are protected by copyright, with all rights reserved, unless otherwise indicated.